.Pharmacolibrary.Drugs.ATC.C.C03DA05 .Pharmacolibrary.Drugs.ATC.C.C03DA05| name: | Finerenone | |
| ATC code: | C03DA05 | |
| route: | oral | |
| compartments: | 2 | |
| dosage: | 20 | mg |
| volume of distribution: | 52.6 | L |
| clearance: | 25.7 | L/h |
| other parameters in model implementation | ||
Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist used in the treatment of chronic kidney disease (CKD) associated with type 2 diabetes. It is approved for reducing the risk of kidney function decline, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in this patient group.
Pharmacokinetic parameters reported in healthy adult subjects after oral administration of finerenone.